{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:14:42Z","timestamp":1775330082719,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jneuroim.2013.11.004","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T11:03:23Z","timestamp":1384599803000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders"],"prefix":"10.1016","volume":"266","author":[{"given":"Michael R.","family":"Pranzatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan R.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.11.004_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(96)01488-6","article-title":"Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury","volume":"752","author":"Banik","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0010","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.yexcr.2007.03.011","article-title":"New movements in neurofilament transport, turnover and disease","volume":"313","author":"Barry","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0015","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mpo.2950210916","article-title":"Adrenocorticotropic hormone-secreting ganglioneuroblastoma associated with opsomyoclonic encephalopathy: a case report with immunohistochemical study","volume":"21","author":"Clerico","year":"1993","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2006\/509476","article-title":"Multiple sclerosis cerebrospinal fluid biomarkers","volume":"22","author":"Giovannoni","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1203\/00006450-199612000-00006","article-title":"Cerebrospinal fluid of newborn infants contains a deglycosylated form of the intermediate filament nestin","volume":"40","author":"Grigelionien\u00e9","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"Gunnarsson","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0304-3940(02)00047-2","article-title":"Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients","volume":"320","author":"Hu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/glia.22276","article-title":"Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis","volume":"60","author":"Huizinga","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1352458512458010","article-title":"CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome","volume":"19","author":"Khalil","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1177\/1352458513482374","article-title":"A comparative study of CSF neurofilament light and heavy chain protein in MS","author":"Kuhle","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0060","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI38003","article-title":"Dysfunctions of neuronal and glial intermediate filaments in disease","volume":"119","author":"Liem","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2008.09.011","article-title":"CSF neurofilament and soluble TNF receptor 1 levels in subacute sclerosing panencephalitis","volume":"205","author":"Matsushige","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2009.01.021","article-title":"Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis","volume":"280","author":"Matsushige","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0075","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.wnl.0000277635.05973.55","article-title":"Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection","volume":"69","author":"Mellgren","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillary acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0090","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000142988.49341.D1","article-title":"Neurofilament and glial fibrillary acidic protein in multiple sclerosis","volume":"63","author":"Norgren","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12035-008-8033-0","article-title":"Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration","volume":"38","author":"Perrot","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21448","article-title":"Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection","volume":"41","author":"Petzold","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/089771501300227297","article-title":"S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury","volume":"18","author":"Pleines","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0205","series-title":"Clinics in Developmental Medicine No. 184-185","first-page":"152","article-title":"Opsoclonus\u2013myoclonus syndrome","author":"Pranzatelli","year":"2010"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0140","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0887-8994(02)00457-5","article-title":"Screening for autoantibodies in children with opsoclonus\u2013myoclonus ataxia","volume":"27","author":"Pranzatelli","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0145","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mds.22941","article-title":"B cell depletion therapy for new-onset opsoclonus-myoclonus","volume":"25","author":"Pranzatelli","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2011.02.012","article-title":"Cerebrospinal fluid oligoclonal bands in childhood opsoclonus\u2013myoclonus","volume":"45","author":"Pranzatelli","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.12.014","article-title":"Key role of CXCL13\/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS","volume":"243","author":"Pranzatelli","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10875-013-9867-4","article-title":"CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids","volume":"33","author":"Pranzatelli","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-10-10","article-title":"BAFF\/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy","volume":"10","author":"Pranzatelli","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0150","doi-asserted-by":"crossref","first-page":"e44320","DOI":"10.1371\/journal.pone.0044320","article-title":"The C-terminal domains of NF-H and NF-M subunits maintain axonal neurofilament content by blocking turnover of the stationary neurofilament network","volume":"7","author":"Rao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1352458509359725","article-title":"Neurofilament light as a prognostic marker in multiple sclerosis","volume":"16","author":"Salzer","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0160","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.08.252","article-title":"Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury","volume":"336","author":"Shaw","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2011.01.025","article-title":"Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke","volume":"304","author":"Singh","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0883073811428816","article-title":"Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome","volume":"27","author":"Tate","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1352458512443092","article-title":"Neurofilaments as biomarkers in multiple sclerosis","volume":"18","author":"Teunissen","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0180","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.11279","article-title":"Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement","volume":"48","author":"Trysberg","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF00344353","article-title":"Opsoclonus\u2013myoclonus syndrome: correlation of radiographic and pathologic observations","volume":"31","author":"Tuchman","year":"1989","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jneuroim.2013.11.004_bb0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneur.1979.00500370081022","article-title":"Neuropathological findings in a patient with neuroblastoma and myoclonic encephalopathy","volume":"36","author":"Ziter","year":"1979","journal-title":"Arch. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813003135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813003135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:25Z","timestamp":1759047685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813003135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0165572813003135"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.11.004","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}